Physician profile
Daniel C Ensley
NPI 1720425424
$2,125.61
in general payments reported to CMS, 2019-2025
9 companies · $485 in 2025
The $485 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $255 · 2021: $478 · 2022: $103 · 2023: $312 · 2024: $174 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $757 · Travel and Lodging: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $757.18 |
| Travel and Lodging | $213.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $897.73 | 2019-2025 | General - Male Sui, Advance Xp |
| Medtronic, INC. | $379.86 | 2021-2023 | Interstim |
| Olympus America INC. | $263.60 | 2021-2025 | Itind System, Olympus, Soltive |
| Procept Biorobotics Corporation | $172.88 | 2025 | |
| Coloplast Corp | $163.26 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $80.17 | 2024-2025 | Orgovyx |
| Myovant Sciences INC. | $77.41 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $54.25 | 2021-2024 | Xiaflex |
| Axonics, INC. | $36.45 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ensley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.